Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Valvo

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
The role of endogenous opioids in the baroreflex dysfunction of dialysis patientsC Zoccali, M Ciccarelli, F Mallamaci, et al.
Nephron|January 1, 1983
Carbohydrate metabolism in patients with nephrotic syndrome and normal renal functionC Loschiavo, A Lupo, E Valvo, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1984
Effects of timolol on blood pressure, systemic hemodynamics, plasma renin activity, and glomerular filtration rate in patients with essential hypertensionE Valvo, L Gammaro, N Tessitore, et al.
Minerva Nefrologica|January 1, 1981
[Evaluation of factor VIII during renal diseases]C Loschiavo, G Previato, G Campo, et al.
Nephron|January 1, 1981
Clinical significance of urinary fibrinogen degradation products in renal disease: study with two methods and correlation with histological findings of intraglomerular coagulationC Loschiavo, G Previato, E Valvo, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1990
Effects of ketanserin administration on lipid metabolism and platelet aggregation in hypertensive patientsC Loschiavo, E Valvo, V Bedogna, et al.
Minerva Nefrologica|January 1, 1979
[Effects of prolonged treatment with labetalol on renal function and on water and saline metabolism in essential and reno-parenchymal hypertension]E Valvo, N Tessitore, G Previato, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1990
Antihypertensive therapy with ketanserin: effects on central and renal hemodynamics, and microalbuminuriaP Casagrande, E Valvo, V Bedogna, et al.
Contributions to Nephrology|January 1, 1987
Hypertension in polycystic kidney diseaseE Valvo, L Gammaro, V Bedogna, et al.
Clinical Nephrology|October 1, 1981
Clinical significance of plasma factor VIII levels in renal diseaseG Previato, C Loschiavo, A Lupo, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
The role of endogenous opioids in the baroreflex dysfunction of dialysis patientsC Zoccali, M Ciccarelli, F Mallamaci, et al.
Nephron|January 1, 1983
Carbohydrate metabolism in patients with nephrotic syndrome and normal renal functionC Loschiavo, A Lupo, E Valvo, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1984
Effects of timolol on blood pressure, systemic hemodynamics, plasma renin activity, and glomerular filtration rate in patients with essential hypertensionE Valvo, L Gammaro, N Tessitore, et al.
Minerva Nefrologica|January 1, 1981
[Evaluation of factor VIII during renal diseases]C Loschiavo, G Previato, G Campo, et al.
Nephron|January 1, 1981
Clinical significance of urinary fibrinogen degradation products in renal disease: study with two methods and correlation with histological findings of intraglomerular coagulationC Loschiavo, G Previato, E Valvo, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1990
Effects of ketanserin administration on lipid metabolism and platelet aggregation in hypertensive patientsC Loschiavo, E Valvo, V Bedogna, et al.
Minerva Nefrologica|January 1, 1979
[Effects of prolonged treatment with labetalol on renal function and on water and saline metabolism in essential and reno-parenchymal hypertension]E Valvo, N Tessitore, G Previato, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1990
Antihypertensive therapy with ketanserin: effects on central and renal hemodynamics, and microalbuminuriaP Casagrande, E Valvo, V Bedogna, et al.
Contributions to Nephrology|January 1, 1987
Hypertension in polycystic kidney diseaseE Valvo, L Gammaro, V Bedogna, et al.
Clinical Nephrology|October 1, 1981
Clinical significance of plasma factor VIII levels in renal diseaseG Previato, C Loschiavo, A Lupo, et al.
Pageof 7